Targeting the fear of gaining weight and body-related concerns in Anorexia Nervosa. Preliminary findings from a Virtual Reality randomized clinical trial

dc.contributor.authorPorras-García, Bruno
dc.contributor.authorSerrano Troncoso, Eduardo
dc.contributor.authorCarulla-Roig, Marta
dc.contributor.authorSoto-Usera, Pau
dc.contributor.authorFerrer, Marta (Ferrer García)
dc.contributor.authorFernández del Castillo-Olivares, Laura
dc.contributor.authorFigueras-Puigderrajols, Natàlia
dc.contributor.authorde la Montaña Santos-Carrasco, Isabel
dc.contributor.authorBorszewski, Bianca
dc.contributor.authorDíaz-Marsá, Marina
dc.contributor.authorGutiérrez Maldonado, José
dc.date.accessioned2022-03-31T16:00:20Z
dc.date.available2022-03-31T16:00:20Z
dc.date.issued2020-12-31
dc.date.updated2022-03-31T16:00:20Z
dc.description.abstractBased on the preliminary findings of a randomized clinical trial with patients with Anorexia Nervosa (AN), this study aims to provide initial evidence of the usefulness of a Virtual Reality body exposure therapy. Method: 17 AN patients (9 in the experimental group, 8 in the control group) participated in the study. Fear of gaining weight (FGW), body anxiety, drive for thinness, body image disturbances (BID), Body Mass Tndex (BMI) and body-related attention were assessed before and after the intervention. Additionally, the experimental group underwent five sessions of VR body exposure therapy within the standard course of CBT, while control patients received the usual CBT. Results: After the intervention, there were clear reductions in ED symptoms in both groups. The reduction was especially marked in the experimental group. Finally, notable changes were recorded in dysfunctional body-related attention and BMI in the experimental group, but not in controls. Conclusion: To the best of our knowledge, this is the first study to focus on treating FGW, body-related concerns and body-related attention in AN using a VR-embodiment based paradigm. To pursue the analysis further, and to assess the effectiveness of this new VR software, larger controlled clinical trials should now be conducted.
dc.format.extent5 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec713226
dc.identifier.issn1554-8716
dc.identifier.urihttps://hdl.handle.net/2445/184584
dc.language.isoeng
dc.publisherInteractive Media Institute
dc.relation.isformatofReproducció del document publicat a: https://www.arctt.info/volume-18-summer-2020
dc.relation.ispartofAnnual Review of CyberTherapy and Telemedicine, 2020, vol. 18, p. 223-227
dc.rightscc-by-nc-nd (c) Interactive Media Institute, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Psicologia Clínica i Psicobiologia)
dc.subject.classificationAnorèxia nerviosa
dc.subject.classificationTeràpia d'exposició
dc.subject.classificationRealitat virtual
dc.subject.classificationAssaigs clínics
dc.subject.otherAnorexia nervosa
dc.subject.otherExposure therapy
dc.subject.otherVirtual reality
dc.subject.otherClinical trials
dc.titleTargeting the fear of gaining weight and body-related concerns in Anorexia Nervosa. Preliminary findings from a Virtual Reality randomized clinical trial
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
713226.pdf
Mida:
180.77 KB
Format:
Adobe Portable Document Format